Beijing Bohui Innovation Biotechnology Group Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Zhiwei Shen

Chief Executive Officer (CEO)

CN¥1.6m

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	1.4yrs
Participación del CEO	n/a
Permanencia media de la dirección	1.4yrs
Promedio de permanencia en la Junta Directiva	3.4yrs

Actualizaciones recientes de la dirección

Recent updates

We Think Beijing Bohui Innovation Biotechnology Group (SZSE:300318) Is Taking Some Risk With Its Debt

Sep 30

CEO

Zhiwei Shen (46 yo)

1.4yrs

Permanencia

CN¥1,595,400

Compensación

Mr. Zhiwei Shen has been Chairman and Non-Independent Director at Beijing Bohui Innovation Biotechnology Group Co., Ltd. (formerly known as Beijing Bohui Innovation Biotechnology Co., Ltd.) since June 01,...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Zhiwei Shen	Chairman of the Board & GM	1.4yrs	CN¥1.60m	sin datos
Jia Liu	Financial Director	1.4yrs	CN¥536.00k	sin datos
Haifeng Dong	Deputy GM	4.3yrs	CN¥834.70k	sin datos
Sixu Chen	Accounting Supervisor	no data	sin datos	sin datos

1.4yrs

Permanencia media

40yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 300318 no se considera experimentado ( 1.4 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Zhiwei Shen	Chairman of the Board & GM	4.4yrs	CN¥1.60m	sin datos
Haifeng Dong	Deputy GM	2.4yrs	CN¥834.70k	sin datos
Jianghong Du	Chairman of the Supervisory Board	10.5yrs	sin datos	3% CN¥ 142.2m
Jun Ban	Independent Director	4.4yrs	CN¥100.00k	sin datos
Xiaosu Zhang	Independent Director	4.4yrs	CN¥100.00k	sin datos
Lanlan Hu	Employee Representative Supervisor	4.4yrs	sin datos	0.00034% CN¥ 16.1k
Jun Yin	Independent Director	1.4yrs	CN¥50.40k	sin datos
Yong Shen	Non-Independent Director	1.4yrs	sin datos	sin datos
Chenglin Zeng	Non-Independent Director	1.4yrs	CN¥1.40m	sin datos
Hengfei Xu	Non-Employee Supervisor	1.4yrs	sin datos	sin datos

3.4yrs

Permanencia media

55.5yo

Promedio de edad

Junta con experiencia: La junta directiva de 300318 se considera experimentada (3.4 años de antigüedad promedio).

Beijing Bohui Innovation Biotechnology Group Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

Beijing Bohui Innovation Biotechnology Group Co., Ltd., Annual General Meeting, May 17, 2024

High number of new directors

Beijing Bohui Innovation Biotechnology Group Co., Ltd., Annual General Meeting, Jun 29, 2023

Less than half of directors are independent

Beijing Bohui Innovation Biotechnology Group Co., Ltd., Annual General Meeting, Jun 24, 2022

High number of new and inexperienced directors

Recent updates

Third quarter 2024 earnings released: CN¥0.005 loss per share (vs CN¥0.01 profit in 3Q 2023)

Beijing Bohui Innovation Biotechnology Group Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024

We Think Beijing Bohui Innovation Biotechnology Group (SZSE:300318) Is Taking Some Risk With Its Debt

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: CN¥0.01 (vs CN¥0.001 in 2Q 2023)

Beijing Bohui Innovation Biotechnology Group Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Beijing Bohui Innovation Biotechnology Group Co., Ltd., Annual General Meeting, May 17, 2024

First quarter 2024 earnings released: EPS: CN¥0.024 (vs CN¥0.006 in 1Q 2023)

Beijing Bohui Innovation Biotechnology Group Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024

New minor risk - Share price stability

Beijing Bohui Innovation Biotechnology Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024

Third quarter 2023 earnings released: EPS: CN¥0.01 (vs CN¥0.024 loss in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.001 (vs CN¥0.008 loss in 2Q 2022)

High number of new directors

Beijing Bohui Innovation Biotechnology Group Co., Ltd., Annual General Meeting, Jun 29, 2023

First quarter 2023 earnings released: EPS: CN¥0.006 (vs CN¥0.016 loss in 1Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: CN¥0.024 loss per share (vs CN¥0.015 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.008 loss per share (vs CN¥0.007 loss in 2Q 2021)

Beijing Bohui Innovation Biotechnology Group Co., Ltd., Annual General Meeting, Jun 24, 2022

Full year 2021 earnings released: CN¥0.39 loss per share (vs CN¥0.009 profit in FY 2020)

High number of new and inexperienced directors

Third quarter 2021 earnings released: CN¥0.015 loss per share (vs CN¥0.027 profit in 3Q 2020)

Second quarter 2021 earnings released: CN¥0.007 loss per share (vs CN¥0.003 loss in 2Q 2020)

First quarter 2021 earnings released: CN¥0.013 loss per share (vs CN¥0.016 loss in 1Q 2020)

New 90-day low: CN¥8.16

New 90-day low: CN¥9.35

New 90-day low: CN¥11.06

New 90-day low: CN¥13.68

Third quarter earnings released

Beijing Bohui Innovation Biotechnology Co., Ltd. to Report Q3, 2020 Results on Oct 27, 2020

New 90-day high: CN¥15.67

Beijing Bohui Innovation Biotechnology Co., Ltd. (SZSE:300318) signed a share transfer agreement to acquire 50% stake in Changzhou Linghang Quantum Biomedical Technology Co., Ltd. from Gao Sheng, Tu Mingyu and Yang Wanbin for CNY 24 million.

First half earnings released

Beijing Bohui Innovation Biotechnology Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

New 90-day high - CN¥8.26

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad